I want to present another view of the patient voice in response to Nyame et al. ([1]) I have been a patient on active surveillance for low-risk Gleason score 6 prostate cancer, diagnosed in 2010. The 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium accepted the poster "Patient Opinions on Controversies: In Regard to Low-Risk Prostate Cancer, Is Gleason 6 the old Gleason 5?".